Dachaigh › Myeloma iomaill › Sgìre Cholumbia › Washington
Sgrùdaidhean clionaigeach Myeloma iomaill ann an Washington, DC
Tha 22 sgrùdaidhean airson Myeloma iomaill a’ lorg phàirtichean aig làraichean ann agus timcheall air Washington (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.
Teacsa sgrùdaidh oifigeil (Beurla)
A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →
Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies
A’ fastadhÌre 1
- National Institutes of Health Clinical Center, Bethesda · 7 mìle air falbh
A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)
A’ fastadhÌre 3
- Research Site, Washington D.C.
Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols
A’ fastadhSgrùdadh amharc
- National Institutes of Health Clinical Center, Bethesda · 7 mìle air falbh
Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer
A’ fastadhÌre 2
- National Institutes of Health Clinical Center, Bethesda · 7 mìle air falbh
Tissue Collection for Studies of Lymph Cancer
A’ fastadhSgrùdadh amharc
- National Institutes of Health Clinical Center, Bethesda · 7 mìle air falbh
Adult Outpatient Linvoseltamab With Tocilizumab Prophylaxis to Mitigate the Risk of Cytokine Release Syndrome (CRS)
A’ fastadhÌre 4
- American Oncology Partners, PA dba The Center for Cancer and Blood Disorders, Bethesda · 7 mìle air falbh
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
A’ fastadhÌre 3
- Center for Cancer and Blood Disorders, Bethesda · 7 mìle air falbh
18F-Fluciclovine PET/CT in Multiple Myeloma
A’ fastadhÌre 2
- National Institutes of Health Clinical Center, Bethesda · 7 mìle air falbh
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
A’ fastadhÌre 3
- American Oncology Partners, PA dba The Center for Cancer and Blood Disorders, Bethesda · 7 mìle air falbh
A Study of Selinexor, in Combination With Carfilzomib, Daratumumab or Pomalidomide in Patients With Multiple Myeloma
A’ fastadhÌre 2
- Lombardi Comprehensive Cancer Center, Washington D.C.
Collection of Tissue Samples for Cancer Research
A’ fastadhSgrùdadh amharc
- National Institutes of Health Clinical Center, Bethesda · 7 mìle air falbh
A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)
A’ fastadhÌre 3
- Georgetown University Medical Center, Washington D.C.
Cevostamab in Combination With Pomalidomide and Dexamethasone Versus Standard of Care in Participants With Previously Treated Multiple Myeloma
A’ fastadhÌre 3
- MedStar Washington Hospital Center MedStar Georgetown Cancer Institute, Washington D.C.
A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Standard of Care in Participants With Relapsed-Refractory Multiple Myeloma (RRMM)
A’ fastadhÌre 2
- GSK Investigational Site, Bethesda · 7 mìle air falbh
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
A’ fastadhÌre 3
- Sibley Memorial Hospital, Washington D.C.
Mosaic Trial for Stem Cell Transplant Recipients
A’ fastadh
- Georgetown University School of Medicine, Washington D.C.
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
A’ fastadhÌre 1
- Maryland Oncology Hematology - Silver Spring /ID# 268562, Silver Spring · 7 mìle air falbh
Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies
A’ fastadhÌre 1/2
- The Center for Cancer and Blood Disorders (CCBD), Bethesda · 7 mìle air falbh
Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation
A’ fastadhÌre 3
- Sibley Memorial Hospital, Washington D.C.
Cancer Experience Registry (CER) for Cancer Patients and Caregivers
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
- Cancer Support Community Research & Training Institute, Washington D.C.
A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)
A’ fastadhÌre 3
- GSK Investigational Site, Washington D.C.
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
A’ fastadhÌre 1/2
- Georgetown Lombardi Comprehensive Cancer Center, Washington D.C.
Sgrùdaidhean Myeloma iomaill ann am bailtean eile
- New York City, NY60 sgrùdaidhean
- Boston, MA42 sgrùdaidhean
- Atlanta, GA42 sgrùdaidhean
- Houston, TX38 sgrùdaidhean
- Durham, NC37 sgrùdaidhean
- Nashville, TN32 sgrùdaidhean
- Denver, CO27 sgrùdaidhean
- Rochester, MN24 sgrùdaidhean
- St. Louis, MO24 sgrùdaidhean
- Columbus, OH24 sgrùdaidhean
- Baldwin Park, CA23 sgrùdaidhean
- Edison, NJ22 sgrùdaidhean
Sgrùdaidhean eile ann an Washington
- Aillse (gach seòrsa)58 sgrùdaidhean
- Aillse Sgamhain Neo-chealla-beag55 sgrùdaidhean
- Aillse a' bhroilleach46 sgrùdaidhean
- Ailse metastatach43 sgrùdaidhean
- Ailseachadh nan Sgamhan41 sgrùdaidhean
- Aillse Prostata38 sgrùdaidhean
- Obesity33 sgrùdaidhean
- Aillse colorectal29 sgrùdaidhean
- Galarachd Cardiovasculach28 sgrùdaidhean
- Aillse sa bhlaire26 sgrùdaidhean
- Leukemia myeloid geur24 sgrùdaidhean
- Cancer Ovarian23 sgrùdaidhean
Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.